Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines.
about
Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaApoptosis Induction by the Total Flavonoids from Arachniodes exilis in HepG2 Cells through Reactive Oxygen Species-Mediated Mitochondrial Dysfunction Involving MAPK ActivationSorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.An updated systematic review of the evolution of ALPPS and evaluation of its advantages and disadvantages in accordance with current evidence.New 'multi-omics' approach and its contribution to hepatocellular carcinoma in China.
P2860
Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Standardizing management of he ...... clinical practice guidelines.
@en
type
label
Standardizing management of he ...... clinical practice guidelines.
@en
prefLabel
Standardizing management of he ...... clinical practice guidelines.
@en
P1433
P1476
Standardizing management of he ...... clinical practice guidelines.
@en
P2093
Peipei Song
P304
P577
2013-10-01T00:00:00Z